肝癌切除联同门静脉癌栓取出术治疗肝癌的临床护理及对患者肝功能指标的影响

Clinical Nursing of Liver Cancer Resection Combined with Portal Vein Tumor Thrombectomy for Liver Cancer and Its Influence on Liver Function Indexes

目的探讨肝癌切除联同门静脉癌栓取出术治疗肝癌的临床护理及对患者肝功能指标的影响。方法研究对象方便选择2016年1月—2018年3月在该院进行治疗的肝癌患者90例,将所选患者随机分为两组,其中对照组肝癌患者采取肝癌切除联同门静脉癌栓取出术进行治疗,研究组肝癌患者在进行肝癌切除联同门静脉癌栓取出术治疗后强化护理。比较两组肝癌患者手术完成之后的临床护理的满意程度,比较两组患者治疗前、后的肝功能指标,比较两组肝癌患者不良反应的发生率。结果对照组总护理满意度为68.9%,研究组总护理满意度为86.7%,研究组患者的临床护理满意度显著高于对照组(χ~2=16.027,P<0.05)。治疗前,两组患者的肝功能指标无显著差异,治疗后,对照组肝脏排泄功能为(57.9±6.8)U/L,凝血酶原时间为(17.2±2.3)s,肝脏合成凝血因子功能为(17.4±3.3)μmol/L,研究组肝脏排泄功能为(33.6±5.2)U/L,凝血酶原时间为(12.9±2.2)s,肝脏合成凝血因子功能为(15.8±2.7)μmol/L,研究组患者的肝功能指标显著优于对照组(t=14.207,16.379,12.315,P<0.05)。对照组总不良反应发生率为82.2%,研究组总不良反应发生率为51.1%,研究组患者的不良反应发生率明显低于对照组(χ~2=7.039,P<0.05)。结论在治疗过程当中,对肝癌患者采取肝癌切除联同门静脉癌栓取出术的同时加强护理可以有效的提高患者的临床护理效果,改善患者的肝功能指标,降低肝癌患者不良反应的发生率,提高患者的治疗效果,该方法可在临床上进行推广。

Objective To investigate the clinical nursing of liver cancer resection combined with portal vein tumor thrombectomy for liver cancer and its influence on liver function indexes. Methods 90 patients with liver cancer who were treated in our hospital from January 2016 to March 2018 were convenient selected and divided into two groups. The patients in the control group were treated with liver cancer resection and portal vein tumor thrombectomy. The liver cancer patients in the study group underwent intensive care after liver cancer resection combined with portal vein tumor thrombectomy. The satisfaction degree of clinical nursing after the operation of the two groups of liver cancer patients was compared. The liver function indexes of the two groups before and after treatment were compared, and the incidence of adverse reactions of the two groups of liver cancer patients was compared. Results The total nursing satisfaction of the control group was 68.9%, and the total nursing satisfaction of the study group was 86.7%. The clinical nursing satisfaction of the study group was significantly higher than that of the control group(χ~2=16.027, P<0.05). Before treatment, there was no significant difference in liver function between the two groups. After treatment, the liver excretion function of the control group was(57.9±6.8)U/L, the prothrombin time was(17.2±2.3)s, and the liver synthesis clotting factor function was(17.4±3.3)μmol/L, the liver excretion function of the study group was(33.6±5.2)U/L, the prothrombin time was(12.9±2.2)s, and the liver synthesis clotting factor function was(15.8±2.7)μmol/L. The liver function index of the study group was significantly better than the control group(t=14.207,16.379, 12.315, P<0.05). The incidence of total adverse reactions was 82.2% in the control group and 51.1% in the study group. The incidence of adverse reactions in the study group was significantly lower than that in the control group(χ~2=7.039, P<0.05). Conclusion In the course of treatment, the liver cancer resection combined with the portal vein tumor thrombectomy and enhanced nursing can effectively improve the clinical nursing effect of patients, improve the liver function index of patients, reduce the incidence of adverse reactions of liver cancer patients, and improve the patient’s therapeutic effect, the method can be promoted clinically.